Molecular Profiling in Advanced Non–Small Cell Lung Cancer: Navigating the New Treatment
Last Modified: April 6, 2015
Corey J. Langer, MD, FACP
Tracey L. Evans, MD
Beth Eaby-Sandy, MSN, CRNP, OCN
CME/CE Released: 02/24/2015; Valid for credit through 02/24/2016.
This activity was developed for a multidisciplinary audience that includes medical, surgical, and radiation oncologists, hematologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with NSCLC.
The goal of this educational program is to provide an update on evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC based on the results of molecular and genetic testing.
Upon completion of this activity, participants should be able to:
- Review evidence-based therapeutic strategies in the individualized treatment of advanced NSCLC
- Integrate molecular and genetic testing results in the treatment of NSCLC
- Discuss interdisciplinary care of patients with advanced NSCLC
Continue to Activity
Select the side effects and forms for your patient's treatment binder
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!